In August 2017, Panalgan products of Cuu Long Pharmaceutical Joint Stock Company – a member of FIT Group was officially launched to the market in the new label with better quality.
The DCL’s Panalgan series is manufactured on modern lines imported from Canada and South Korea with the better packaging quality, the quality of materials following the standards of United States Pharmacopoeia (USP), and it has quick and effective analgesic, antipyretic, and pain-relief effect.
According to the Board of Directors of DCL, changing and improving the label, product quality is to improve the effectiveness of treatment and quality of service to patients.
In addition, the continuous improvement of the label and product packaging is also an important first step in positioning DCL’s brand in the pharmaceutical market in Vietnam. This is included in the development strategy that FIT Group has oriented from the beginning of 2017 to DCL in particular and the member companies of the FIT Group in general.
In parallel with the change of label, DCL is also promoting Panalgan products such as: Panalgan antipyretic, Panalgan fever, Panalgan pain relief… through OTC channel (the product distribution channel from the manufacturer through the pharmacy and directly to the consumer without any other intermediate stage) to ensure that consumers do not have to pay too high prices when using the products of the company.
With the orientation from its parent company FIT Group, the change of packaging for the Panalgan line has confirmed the efforts of the company in the continuous improvement of product quality, this is also the first step for DCL to step by step change its position in the pharmaceutical market in Vietnam.
New label of Panalgan series:
